Clinical Trial Update: LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update for LiO-AD (lithium orotate) in Alzheimer's disease, focusing on feasibility, biomarker engagement, and clinical response; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lithium Orotate (lithium orotate)

Snippet

Sponsor: Johns Hopkins University | Conditions: Alzheimer s Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING